title: Hemicrania continua: recent treatment strategies and diagnostic evaluation.
abstract: Hemicrania continua (HC) is a primary headache disorder that is characterized by a continuous unilateral headache of moderate severity, exacerbations of severe pain, and complete responsiveness to indomethacin. HC was once thought to be a rare headache disorder, but now many cases have been reported. It is an underecognized headache syndrome. HC can be of continuous or remitting form. Variants such as hemicrania continua with aura have been described, and secondary cases may occur. Indomethacin is the best treatment, although HC could respond to other nonsteroidal anti-inflammatory drugs, such as the selective cyclo-oxygenase-2 inhibitors.
authors.affiliation: Sao Paulo Headache Center, Rua. Maestro Cardim 887, Sao Paulo, 01323-001, Brazil. marioperes@yahoo.com
authors.forename: Mario F P
authors.initials: MF
authors.lastname: Peres
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D002908:Chronic Disease; D005260:Female; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use*; D008297:Male; D008881:Migraine Disorders / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology; D017678:Sex Distribution
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D007213:Indomethacin